IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

FDA bans imports of Sun Pharma's products from plant in India

4:58 AM MDT | March 13, 2014 | Natasha Alperowicz

The FDA has imposed a ban on imports from Sun Pharma’s (Mumbai) Karkhadi, Gujarat plant in India. The facility makes APIs and formulations.  The FDA has issued an import alert on the plant. The ban is the latest in a series of FDA clampdowns on Indian drug makers. It follows FDA’s ban on all Ranbaxy Laboratories plants in India over production quality lapses.   India is a leading drug exporter to the United States, supplying about 40% of generic and over-the-counter drugs. The ban on the Sun Pharma unit indicates that it has not met cGMP...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa